PTH and chronic kidney disease: Identifying and controlling SHPT at early stages (i.e., not waiting until patients start dialysis to begin treatment and ensuring treatment begins in patients with DD-CKD before PTH is significantly elevated [e.g., >600 pg/mL]) was considered an important goal but has many technical and administrative difficulties.